National Pharmacology Directors of Graduate Programs Meeting

全国研究生项目药理学主任会议

• 批准号: 8597091
• 负责人: Joey V. Barnett
• 金额: $ 0.75万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-05-15 至 2018-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8597091
• 关键词: Academia; Address; Animals; Area; Biomedical Research; Cell physiology; Discipline; Disease; Doctor of Philosophy; Drug Industry; Drug Kinetics; Environment; Exposure to; Face; Fostering; Future; Goals; Government; Graduate Education; Growth; Human; Human Biology; Individual; Industry; Institutes; Interdisciplinary Study; Knowledge; Laboratories; Lead; Molecular; Organism; Outcome; Patient Care; Pharmaceutical Preparations; Pharmacology; Physiological; Physiology; Psychological reinforcement; Research; Research Personnel; Science; Scientist; Shapes; Students; Systems Biology; Training; Training Programs; Translational Research; Uncertainty; Universities; Work; base; drug metabolism; human disease; improved; insight; interest; meetings; pre-doctoral; programs; public health relevance; response; skills; success; therapy development

DESCRIPTION (provided by applicant): The integration of our scientific knowledge at the molecular, cellular, and organismal levels is critical to impacting disease in humans. As our insight into molecular and cellular processes has grown, emphasis in many Ph.D. training programs has shifted away from integrated (whole animal or systems) biology, including the biology of humans. The lack of an available scientific workforce with an understanding of integrated or human biology, including drug metabolism and pharmacokinetics, and an appreciation of the unique challenges of converting discoveries into therapies will delay the application of discoveries at the molecular and cellular levels to human disease. Scientists trained in the disciplines of Pharmacology and Physiology form an important part of this necessary workforce. This meeting addresses critical issues related to training Pharmacologists and Physiologists and has been planned in response to a perceived and real decline in training programs in these disciplines. The goals of this meeting are to identify common problems and opportunities that face Ph.D. training programs in Pharmacology and Physiology and how best to provide training in these disciplines that are key to translational research. The target audienc for this meeting is Directors of Graduate Training Programs in Pharmacology, Physiology, or other biomedical sciences. This meeting will provide a unique opportunity for these scientists to exchange information and to interact with leaders in industry, government, and academia who help shape these disciplines. A continuing dialogue among Directors of training programs and other scientists with an interest in Ph.D. training is identified as a desired major outcome.

描述（由申请人提供）：我们在分子、细胞和生物体水平上的科学知识的整合对于影响人类疾病至关重要。随着我们对分子和细胞过程的深入了解，许多博士学位的重点已经增加。培训计划已经从综合（整个动物或系统）生物学，包括人类生物学转移。缺乏了解综合或人类生物学（包括药物代谢和药代动力学）的科学工作人员，以及缺乏对将发现转化为治疗方法的独特挑战的认识，将推迟在分子和细胞水平上将发现应用于人类疾病。在药理学和生理学学科培训的科学家形成了这一必要的劳动力的重要组成部分。本次会议讨论了与药理学家和生理学家培训相关的关键问题，并计划对这些学科培训计划的感知和真实的下降做出回应。本次会议的目标是确定面临的共同问题和机会博士。药理学和生理学的培训计划，以及如何最好地提供这些学科的培训，这些学科是转化研究的关键。本次会议的目标听众是药理学、生理学或其他生物医学科学研究生培训项目的负责人。这次会议将为这些科学家提供一个独特的机会，与帮助塑造这些学科的工业界、政府和学术界的领导者交流信息和互动。培训项目主任和其他对博士学位感兴趣的科学家之间的持续对话培训被确定为一项预期的主要成果。